Ketamine has been in use since its development as a dissociative anesthetic in the 1960s, but it was largely confined to the operating theater or austere environments until used by emergency physicians to facilitate painful procedures in children. As the unique effects of ketamine across its dose-response curve were understood, new applications emerged. In low doses, ketamine has found an important role alongside or instead of opioids in the management of severe pain, and methods to slow its absorption allow higher, more effective doses while attenuating psychoperceptual effects. Ketamine’s unique anesthetic properties have inspired its use as an induction agent for intubation without a paralytic and for the rapid, safe control of dangerously agitated patients. Emerging uses for ketamine in acute care include treatment for status epilepticus and alcohol withdrawal syndrome; however, its most important rising indication may be as an emergency treatment of depression and suicidality.
How would you manage these patients? Subscribe for evidence-based best practices and to discover the outcomes.
4. “We used propofol for RSI induction because ketamine is contraindicated in head trauma patients.” Ketamine does not meaningfully increase intracranial pressure and, unlike propofol, maintains blood pressure–a critical goal in neuro-resuscitation.
7. “We gave large doses of midazolam, but couldn’t calm the patient in time to prevent a bad outcome.” Dissociative-dose ketamine is the best agent to calm the uncontrollably violent patient, especially patients who are resistant to alternative treatments. Once a dissociative dose of ketamine is administered, the patient requires continuous resuscitation-level monitoring for the duration of dissociation.
8. “The patient had a Glasgow Coma Scale score of 3 after EMS gave a big dose of ketamine for agitation, so he required intubation.” Most patients treated for agitation with dissociative-dose ketamine will emerge from dissociation safely and not require intubation; however, preparation for intubation and vigilant monitoring of ventilation for the duration of dissociation is required.
Subscribe to access the complete Risk Management Pitfalls to guide your clinical decision making.
Subscribe for full access to Figures.
Buy this issue and
Following are the most informative references cited in this paper, as determined by the authors.
3. Gerber M. “Speakers Take a Close Look at Prehospital Ketamine Use at EMS World Expo.” 2023. Accessed April 10, 2024. (Website article)
4. Strayer R. “The Ketamine Brain Continuum.” 2013. Accessed April 10, 2024. (Website article)
9. American College of Emergency Physicians. Sub-dissociative dose ketamine for analgesia. 2018. Accessed April 10, 2024. (Policy statement)
13. * Clattenburg EJ, Hailozian C, Haro D, et al. Slow infusion of low-dose ketamine reduces bothersome side effects compared to intravenous push: a double-blind, double-dummy, randomized controlled trial. Acad Emerg Med. 2018;25(9):1048-1052. (Randomized controlled trial; 59 patients) DOI: 10.1111/acem.13428
23. * Dove D, Fassassi C, Davis A, et al. Comparison of nebulized ketamine at three different dosing regimens for treating painful conditions in the emergency department: a prospective, randomized, double-blind clinical trial. Ann Emerg Med. 2021;78(6):779-787. (Randomized controlled trial; 120 patients) DOI: 10.1016/j.annemergmed.2021.04.031
49. * Green SM, Roback MG, Krauss BS, et al. Unscheduled procedural sedation: a multidisciplinary consensus practice guideline. Ann Emerg Med. 2019;73(5):e51-e65. (Society guideline) DOI: 10.1016/j.annemergmed.2019.02.022
74. * Green SM, Andolfatto G, Krauss BS. Ketamine and intracranial pressure: no contraindication except hydrocephalus. Ann Emerg Med. 2015;65(1):52-54. (Editorial) DOI: 10.1016/j.annemergmed.2014.08.025
95. * Merelman AH, Perlmutter MC, Strayer RJ. Alternatives to rapid sequence intubation: contemporary airway management with ketamine. West J Emerg Med. 2019;20(3):466-471. (Review) DOI: 10.5811/westjem.2019.4.42753
100. Strayer R. “Ketamine-Only Breathing Intubation.” 2019. Accessed April 10, 2024. (Website article)
102. *Thiessen MEW, Godwin SA, Hatten BW, et al. Clinical Policy: critical issues in the evaluation and management of adult out-of-hospital or emergency department patients presenting with severe agitation: approved by the ACEP Board of Directors, October 6, 2023. Ann Emerg Med. 2024;83(1):e1-e30. (Clinical policy) DOI: 10.1016/j.annemergmed.2023.09.010
105. *Barbic D, Andolfatto G, Grunau B, et al. Rapid agitation control with ketamine in the emergency department: a blinded, randomized controlled trial. Ann Emerg Med. 2021;78(6):788-795. (Randomized controlled trial; 80 patients) DOI: 10.1016/j.annemergmed.2021.05.023
114. American College of Emergency Physicians. ACEP Task Force report on hyperactive delirium with severe agitation in emergency settings. 2021. Accessed April 10, 2024. (Task force report)
115. American Medical Association. Use of drugs to chemically restrain agitated individuals outside of hospital settings. Report 2 of the Council on Science and Public Health. 2021. Accessed April 10, 2024. (AMA report)
116. American Society of Anesthesiologists; American College of Emergency Physicians. ASA/ACEP joint statement on the safe use of ketamine in prehospital care. 2020. Accessed April 10, 2024. (Joint statement)
143. Megli D. “Ketamine Therapy for Mental Health a ‘Wild West’ for Doctors and Patients.” KFF Health News. 2024. Accessed April 10, 2024. (News article)
Subscribe to get the full list of 147 references and see how the authors distilled all of the evidence into a concise, clinically relevant, practical resource.
Keywords: ketamine, dissociative, procedural, analgesia, emergence, intubation, rapid, delayed, agitation, asthma, status epilepticus, depression, alcohol
Reuben J. Strayer, MD
Natalie Kreitzer, MD, MS; Andrew Schmidt, DO, MPH
May 1, 2024
May 1, 2027   CME Information
4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAFP Prescribed Credits, 4 AOA Category 2-B Credits. Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 4 Pharmacology CME credits and 1 Pain Management CME credit, subject to your state and institutional approval.